Satori Neuro
Satori Neuro focuses on transformational companies offering innovative brain and mental health solutions
THE FUTURE OF HUMAN FLOURISHING
Current innovations in neuroscience are on the verge of transforming how we approach brain and mental health solutions. Thanks to recent advances, we have learned more about the human brain in the last five years than we previously learned in the last 50 – and that knowledge is rapidly transforming into real-world applications that hold the promise of completely transforming our approach to mental health challenges we’ve struggled with throughout human history.
A POWERFUL PARTNERSHIP
Satori Neuro is led by chief investment officer Dr. Amy Kruse, who has more than 20 years of experience in science, technology, and innovation, with a special focus on neurotechnology and human performance. Along with Satori principals’ operating experience in building and managing successful companies, we believe Amy’s unique expertise, experience, and relationships give us a distinct advantage in recognizing the most promising and innovative businesses in the sector.
AN EXPANSIVE INVESTMENT APPROACH
Our focus is identifying the most promising companies and finding intersections where breakthrough treatments combine with disruptive business models to create value. Our stage-agnostic approach provides the flexibility to invest in what we believe to be the most compelling companies regardless of size and stage.
THE SATORI NEURO ECOSYSTEM
Ancient wisdom paired with modern technology is unlocking a transformative new era of neuroscience and mental health solutions.
These breakthrough treatments include a range of technologies:
- Psychedelic medicine
- Precision psychiatry
- Non-invasive neurostimulation
- Virtual / augmented reality
- Brain measurement and imaging devices
- AI-based digital tools
That can provide solutions to a wide spectrum of challenges:
- Treatment-resistant depression
- Post-traumatic stress disorder
- Addiction/substance abuse
- Anxiety
- Neurological disorders
- Cognitive impairment
WHY SATORI NEURO?
We believe successful investors in this space will:
- Have access to compelling opportunities, entrepreneurs, and business founders.
- Leverage relevant experience, knowledge and relationships to assess those opportunities.
- Serve as a trusted and value-added resource to the companies in its portfolio.
The leadership of Dr. Amy Kruse – a scientist, investor, and entrepreneur with more than 20 years of experience and a broad network of key relationships – combined with Satori’s institutional strength creates what we see as unique access to opportunities, an advantage in conducting rigorous due diligence, and the ability to serve as a value-added partner to the companies in our portfolio.